Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on Reduced Dose Intensity of Pembrolizumab and Drug Combination for Patients with Advanced or Metastatic Cancer Responding to Standard Immunotherapy

    Not recruiting

    1 1 1 1
    France
  • Study on Capsaicin Patch and Amitriptyline for Neuropathic Pain in Head and Neck Cancer Patients in Remission

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on the Safety and Effects of Tolinapant in Patients with Advanced Solid Tumors and Lymphomas

    Not recruiting

    1 1
    Investigated drugs:
    Italy Spain
  • Study of NBTXR3 and Cetuximab with Radiotherapy for Elderly Patients with Advanced Head and Neck Cancer Not Eligible for Platinum Chemotherapy

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Germany Greece
  • Study on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1
    Investigated drugs:
    Austria Denmark Finland France Germany Italy +3
  • Study of IPN01194 for Adults with Advanced Solid Tumors, Including Melanoma, Head and Neck Cancer, Pancreatic Cancer, and Colorectal Cancer

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France Spain
  • Study of ALX148 and Pembrolizumab for Patients with Advanced Head and Neck Cancer

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium The Netherlands Spain
  • Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

    Not recruiting

    1 1 1
    Belgium Spain
  • Study of ALX148, Pembrolizumab, and Chemotherapy for Patients with Advanced Head and Neck Cancer

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium The Netherlands Spain
  • Study of Monalizumab and Cetuximab for Patients with Recurrent or Metastatic Head and Neck Cancer Previously Treated with an Immune Checkpoint Inhibitor

    Not recruiting

    1 1 1
    Investigated diseases:
    Germany